21世纪经济报道记者 易妍君 21世纪经济报道记者了解到，今年以来，除了签约资产规模增长，部分券商基金投顾业务的盈利客户比 例、投顾策略业绩也有不错的表现。 值得注意的是，伴随AI的发展，券商对于基金投顾业务的发展模式有了更加深入的探索。 公募基金投顾业务试点转常规正在推进中，券商加速向"买方投顾"转型。 除了中金财富买方投顾资产保有规模跨越1000亿元里程碑，近期，多家券商释放了基金投顾业务稳步增 长的积极信号。 "基金投顾业务未来应该朝着账户管理模式发展，强调资产配置能力，并呈现投资策略不断丰富、服务 及收费模式多样化以及千人千面的特点。"国信证券有关人士向记者指出。 增长势头 近期，多家券商公布了旗下基金投顾业务最新规模，均呈现增长势头。 7月中旬，中金财富透露，公司买方投顾资产保有规模跨越1000亿元。其买方投顾服务矩阵包括"中国 50""微50""金选FOF""公募50"等一站式产品配置解决方案及"股票50""ETF50"等交易资产解决方案。 华宝证券基金投顾业务规模、客户数双双增长。截至7月中旬，华宝证券基金投顾规模突破55亿元，客 户数超过15万户，分别较去年末增长40%和20%，增长规模主要来 ...

近期大火的AI、国防军工则转向回调，但短线行情表现似乎并未动摇资金信心。创业板人工智能ETF（159363）早盘一度下挫3%，资金积极抢筹，全天获 净申购4600万份；国防军工ETF（512810）新高后回落，尾盘突发溢价飙升，或有大额买盘资金介入。 8月7日，A股三大指数走势分化，沪指四连阳，盘中最高上探3645.12点，续刷阶段新高，创业板指、深证成指收跌，两市成交额1.83万亿元，环比放量。 | 序号 代码 | | 名称 | 两日图 现价 涨跌 涨跌幅 ▼ | | --- | --- | --- | --- | | 1 159876 | | 有色龙头ETF | m/ 0.664 0.010 1.53% | | 2 - 1 | 159707 | 地产ETF | -0.640 0.008 1.27% | | 3 | 515260 | 电子ETF | . 0.975 0.006 0.62% | | 4 | 512800 | 银行ETF | 10.000 0.874 0.004 0.46% | | 5 Hill | 512170 医疗ETF | | 2. Jan 0.369 0.001 0.27% | 盘面热点 ...

Core Viewpoint - The brokerage sector is experiencing a positive trend driven by multiple favorable factors, including a significant increase in A-share financing balance and strong mid-term performance forecasts from listed brokerages [1][3][6]. Group 1: Market Performance - The A-share market is showing strong momentum, with the Shanghai Composite Index frequently reaching new highs this year [3]. - The financing balance in the A-share market has surpassed 2 trillion yuan, marking the first time since the 2015 bull market that it has reached this level [3]. - The brokerage ETF (512000) has seen a price increase of over 1% in early trading, indicating positive buying sentiment [1]. Group 2: Brokerage Stock Performance - Most brokerage stocks are performing well, with notable gains such as Caida Securities hitting the daily limit and a 7.16% increase, while Western Securities and Oriental Securities also saw gains of 2.69% and 1.57% respectively [2][4]. - A total of 31 listed brokerages have reported positive mid-term performance forecasts, with 13 of them expecting to double their net profits year-on-year [3][5]. Group 3: Investment Opportunities - Analysts suggest that the brokerage sector is poised for continued growth due to favorable mid-term earnings forecasts, capital market reforms, and liquidity easing [6]. - The brokerage ETF (512000) has attracted significant inflows, totaling 361 million yuan over four consecutive days, indicating strong investor interest [6][8]. - The sector's overall valuation remains at a historically low level, suggesting potential for recovery and growth [6].

8月7日，A股三大指数走势分化，沪指四连阳，盘中最高上探3645.12点，续刷阶段新高，创业板指、深 证成指收跌，两市成交额1.83万亿元，环比放量。 | 序号 代码 名称 | 两日图 现价 涨跌 涨跌幅 ▼ | | --- | --- | | 1 159876 有色龙头ETF > ~~~ 0.664 0.010 1.53% | | | 2 159707 地产ETF | -0.640 0.008 1.27% | | 3 515260 电子ETF | 0.975 0.006 0.62% | | 4 512800 银行ETF | brund 0.874 0.004 0.46% | | 5 512170 医疗ETF | 2. Am 0.369 0.001 0.27% | 盘面热点杂乱，全球贸易波动加剧，特朗普表示美国将对芯片和半导体征收约100%的关税，半导体、 消费电子联袂走强，电子ETF（515260）场内价格一度上涨1.8%。 地产午后拉升，代表A股龙头地产行情的地产ETF（159707）场内收涨逾1%。上海宣布明年将启动城中 村整体改造项目，2027年全面完成小梁薄板房屋改造，继续开展老旧小区改造。 银行延 ...

证券代码：600909 证券简称：华安证券 公告编号：2025-049 华安证券股份有限公司 2025 年度第七期短期融资券发行结果公告 本公司董事会及全体董事保证本公告内容不存在虚假记载、误导性陈述或 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 华安证券股份有限公司 2025 年度第七期短期融资券已于 2025 年 8 月 7 日发 行完毕，相关发行情况如下： 特此公告。 华安证券股份有限公司董事会 2025 年 8 月 8 日 | 短期融资券名称 | 华安证券股份有限公司 | 2025 | 年度第七期短期融资券 | | --- | --- | --- | --- | | 短期融资券简称 | 25 华安证券 CP007 | 期限 | 182 天 | | 短期融资券代码 | 072510154 | 发行日 | 2025 年 8 月 6 日 | | 起息日 | 2025 年 8 月 7 日 | 兑付日 | 2026 年 2 月 5 日 | | 计划发行总额 | 10 亿元 | 实际发行总额 | 10 亿元 | | 票面利率 | 1.63% | 发行价格 | 100 元/张 | 本期发行短期融资券 ...

新浪期货 根据交易所数据，截至8月07日收盘主力合约鸡蛋2509,涨跌+1.16%,成交量18.88万手，持仓数据显示前20席位呈现净 空，差额头寸为5507手。 鸡蛋期货全合约总计成交37.48万手，比上一日减少2.14万手。全合约前20席位多头持仓32.56万手，比上一日增加7256手。全合约 前20席位空头持仓35.56万手，比上一日增加5899手。 根据合并数据显示，多头前三席位为国泰君安，总持仓33253、中信期货，总持仓27403、方正中期，总持仓25217；空头前三席位 为国泰君安，总持仓44394、中信期货，总持仓31803、中信建投，总持仓26161； 主力合约前20席位中，多头增仓前三名分别是：中泰期货、持仓5287、增仓402，平安期货、持仓4218、增仓337，银河期货、持 仓6587、增仓144；多头减仓前三名分别是：国泰君安、持仓8713、减仓-1455，东证期货、持仓5405、减仓-438，中信期货、持 仓5734、减仓-374； 主力合约前20席位中，空头增仓前三名分别是：方正中期、持仓6782、增仓579，中信期货、持仓8323、增仓460，申银万国、持 仓3114、增仓30 ...

Market Performance - On August 7, the securities sector rose by 0.11% compared to the previous trading day, with Caida Securities leading the gains [1] - The Shanghai Composite Index closed at 3639.67, up 0.16%, while the Shenzhen Component Index closed at 11157.94, down 0.18% [1] Individual Stock Performance - Caida Securities (600906) closed at 7.78, with a gain of 7.16% and a trading volume of 2.51 million shares, amounting to a turnover of 1.964 billion yuan [1] - Other notable performers included Western Securities (002673) with a closing price of 8.78, up 2.69%, and Dongfang Securities (600958) at 11.63, up 1.57% [1] Fund Flow Analysis - The securities sector experienced a net outflow of 522 million yuan from institutional investors, while retail investors saw a net inflow of 89.34 million yuan [2] - Notable net inflows from retail investors were observed in Caida Securities, with a net inflow of 23.2 million yuan, despite a net outflow from institutional and speculative funds [2]

Core Viewpoint - The report from Huazhong Securities indicates that Aorijin's investment in overseas production lines is expected to improve profitability through capacity expansion [1] Group 1: Investment Details - Aorijin plans to invest approximately RMB 441.6 million in the construction of a two-piece can production line project in Thailand, which includes building construction, equipment relocation, new equipment purchase, and working capital [1] - This overseas investment aligns with the company's international development strategy and aims to expand its two-piece can business in Southeast Asia and Central Asia [1] Group 2: Market Position and Strategy - The project is expected to help Aorijin optimize its product structure and enhance its market share in overseas markets, thereby increasing its international competitiveness and brand influence [1] - As the market share for two-piece cans becomes more concentrated, the company's bargaining power and profitability are anticipated to improve [1] Group 3: Business Performance - Aorijin, as a leading enterprise in the metal packaging industry, has shown significant results in optimizing its three-piece can product categories and expanding its customer base, leading to stable revenue growth [1] - The successful acquisition of COFCO Packaging has significantly increased the market share of the two-piece can business, enhancing bargaining power and providing substantial potential for profitability improvement [1] - The report maintains a "buy" rating for the company [1]

Group 1 - The core viewpoint of the article is that Huazhong Securities has given a "buy" rating to Aorijin (002701.SZ) based on its recent announcement regarding the investment in overseas production lines [2] - The company is actively expanding into international markets, which is expected to enhance its profitability [2] - The metal packaging industry is experiencing accelerated consolidation, and the trend against internal competition is likely to support profit recovery [2]

Core Viewpoint - The article discusses the recent performance of Xianjian Technology (01302) and the impact of new pricing regulations on the medical device industry in China, particularly focusing on the aortic stent market and the expected recovery in the sector by 2025 [1] Group 1: Company Performance - Xianjian Technology's stock rose over 10%, currently trading at 2.2 HKD with a transaction volume of 214 million HKD [1] - The company is affected by new pricing regulations set by the National Healthcare Security Administration, which aims to reduce excessive markups in the supply chain [1] Group 2: Industry Insights - The price adjustments due to centralized procurement are expected to lead to a decline in the ex-factory prices of related products, impacting the company's revenue and profit in the second half of 2024 [1] - A one-year price adjustment period is anticipated to gradually clear by the second half of 2025, potentially reversing the current challenges faced by the company [1] - Citic Securities predicts that as policies ease and centralized procurement clears, many medical device companies will see performance and valuation recovery [1] - The medical device sector is expected to present increasing investment opportunities, particularly in international markets, with several companies projected to achieve high growth in international business by 2025 [1] - The strong performance of the Hong Kong medical device sector this year is likely to influence the A-share market, highlighting ongoing investment opportunities in both markets [1]